Healthcare is a sector characterised by strong growth and increasing complexity. Our clients include hospitals, doctors, insurance companies, pharmaceutical companies, and biotechnology and medical technology start-ups, as well as public administration agencies and healthcare organisations. We have considerable expertise in healthcare law and sector-specific life science issues. Our legal expertise is combined with a deep market knowledge and insight. We are able to assist our clients on issues ranging from market research and product development to product implementation and defence – and at a level that goes beyond mere legal issues.


Healthcare & Life Sciences
Introduction

Healthcare is a sector characterised by strong growth and increasing complexity. Our clients include hospitals, doctors, insurance companies, pharmaceutical companies, and biotechnology and medical technology start-ups, as well as public administration agencies and healthcare organisations. We have considerable expertise in healthcare law and sector-specific life science issues. Our legal expertise is combined with a deep market knowledge and insight. We are able to assist our clients on issues ranging from market research and product development to product implementation and defence – and at a level that goes beyond mere legal issues.

Experts Products & experience

Our key areas of activity are:

  • Swiss regulatory law, including: pricing and reimbursement claims, supervisory control and execution measures, regulations and procedural guidelines for clinical trials, registration of medical products and equipment, and regulations on the advertising and promotion of medical products and equipment at the federal level and in all cantons.
  • Offering assistance and sector-specific expertise for service providers such as hospitals, health maintenance organisations (HMOs), preferred provider organisations (PPOs), residential homes and assisted-living arrangements, doctors and their networks, and associations in all matters (including public-law and administrative issues, price setting and reimbursement procedures, contractual negotiations with insurers and network partners, and compliance with directives on bribery and corruption)
  • Providing sector-specific support on entering into employment relationships, including drafting employment, management, outsourcing and employment leasing contracts, as well as obtaining the necessary permits, and advising on existing regulations in health and employment law and the requirements of social security law
  • Advising on data protection/non-disclosure obligations in healthcare and life science sectors
  • Representing our clients before all state courts, professional tribunals, and arbitration panels in industry-specific disputes
Publications





Urteil des Bundesverwaltungsgerichts "Hors Liste"(Judgement of the Federal Administrative Court on the Matter of "Unlisted Products")

by Daniel Zimmerli
in: "Life Science Recht" 3/2018




§ 35 Einführung in die Grundlagen und die Systematik des schweizerischen Medizinprodukterechts(Introduction to basic principles of Swiss medical device regulation)

by Michael Isler
co-authored by Alexander Gutmans
in: Ehrhard Anhalt / Peter Dieners (Editor[s]), "Medizinprodukterecht – Praxishandbuch"
2. Auflage, Munich 2017, pp. 1201 - 1228


Kommentar zu Art. 15 und 16, Vorbem. zu Art. 51a–60 und Art. 51a–60 des Bundesgesetzes über den Schutz von Marken und Herkunftsangaben (MSchG)(Commentary on art. 15 and 16, preliminary remarks to art. 51a–60 and art. 51a–60 of the Federal Act on the Protection of Trade Marks and Indications of Source)

by Markus R. Frick
in: David/Frick (Editor[s]), "Basler Kommentar Markenschutzgesetz Wappenschutzgesetz"
3. Auflage, Basel 2017, pp. 490–524, 913–1056 (ISBN/ISSN: 978-3-7190-3553-2)


Kommentar zu Art. 13 und 14 des Bundesgesetzes über den Schutz von Marken und Herkunftsangaben des Bundesgesetzes über den Schutz von Marken und Herkunftsangaben (MSchG)(Commentary on art. 13 and 14 of the Federal Act on the Protection of Trade Marks and Indications of Source (FTA))

by Michael Isler
in: David/Frick (Editor[s]), "Basler Kommentar Markenschutzgesetz Wappenschutzgesetz"
3. Auflage, Basel 2017, pp. 442–490


Der "Yasmin"-Entscheid - kritische Würdigung de lege ferenda(The "Yasmin" ruling - critical evaluation de lege ferenda)

by Daniel Staffelbach
co-authored by Kerstin Noëlle Vokinger
in: "HAVE" 1 January 2017, pp. 118-121





Arbitration Session an der MARQUES Arbitrating and Mediating Trademarks Tagung(Arbitration Session at MARQUES Arbitrating and Mediating Trademarks Seminar)

Speaker: Markus R. Frick
MARQUES Arbitrating and Mediating Trademarks
London 19 April 2016




Kommentar zu Artikel 8-11, 30 VegüV(Commentary on articles 8-11, 30 VegüV)

by Alex Nikitine
in: Watter/Vogt (Editor[s]), "Basler Kommentar, Verordnung gegen übermässige Vergütungen bei börsenkotierten Aktiengesellschaften"
Basel 2015


Vertragshandbuch Pharma und Life Sciences – Besonderheiten des Schweizer Rechts, 10. Kapitel(Compendium of contracts in Pharma and Life Sciences, chapter with regard to legal specifics in Switzerland)

co-authored by Simon Holzer, Michael Ritscher and Andreas Wildi
2015, pp. 959 ff







Particular Aspects of Online Marketing, Social Media and Consumer Apps in Life Sciences

Speakers: Michael Isler and Stefan Maassen
AIJA Seminar Life Science 2.0 – Risks and side-effects of new trends
Basel 13 March 2015 (http://www.aija.org/events/life-sciences)


Outsourcing 2015

co-authored by David Vasella and Nicola Benz
in: "Getting the Deal Through"
London 2015


HIV-Prävention in der Schweiz. Entwicklungen und Perspektiven. Die Dekriminalisierungsaspekte und ihre rechtlichen Folgen(HIV prevention in Switzerland. Developments and perspectives. The aspects of decriminalisation and their legal consequences)

by Kerstin Noëlle Vokinger
co-authored by Thomas Gächter
in: "Tagungsband Workshop des AIDS-Ausschusses der Ärztekammer Mecklenburg-Vorpommern" 1 January 2015, pp. 29-43


Besprechung des Urteils BVGE 2013/45 zur Planung der hochspezialisierten Medizin mit besonderer Berücksichtigung von medizinischen Aspekten(Review of the judgement of the Swiss Federal Administrative Court 2013/45 on the planning of highly specialised medicine with particular consideration of the medical aspects)

by Kerstin Noëlle Vokinger
in: "Jusletter" 1 August 2014


Spitalsubventionen und neue Spitalfinanzierung - Ein Rechtsvergleich kantonalen Wirkens im Spannungsverhältnis von Wettbewerbsneutralität und kantonaler Autonomie(Hospital subsidies and new hospital financing - a legal comparison of cantonal activities against the backdrop of the tense relationship between competitive neutrality and cantonal autonomy)

by Kerstin Noëlle Vokinger
co-authored by Thomas Poledna
in: "Jusletter" 1 August 2014



Impact of Variable CYP Genotypes on Breast Cancer Relapse in Patients Undergoing Adjuvant Tamoxifen Therapy

by Kerstin Noëlle Vokinger
co-authored by Jessica Mwinyi, Alexander Jetter, Urs Breitenstein, Christian Hiller, Gerd A. Jullak-Ublick and Andreas Trojan
in: "Cancer Chemotherapy Pharmacology" 1 June 2014, pp. 1181-1188




Eine Wegleitung für die medizinische und pharmazeutische Praxis sowie für Behörden und Versicherer(A guide for medical doctors, pharmacists, authorities and payers)

co-authored by Max Giger, Urs Saxer, Andreas Wildi and Markus B. Fritz
in: Verlagsforum Gesundheitswesen (Editor[s]), "Arzneimittelrecht"
Zurich 2013


Commentary on Article 194 PILS

co-authored by Micha Bühler and Michael Cartier
in: Manuel Arroyo (Editor[s]), "Arbitration in Switzerland – The Practitioner’s Guide"
The Hague 2013


Commentary to Art. 5 to 8 of the Swiss Rules of International Arbitration

co-authored by Micha Bühler and Michael Feit
in: Zuberbühler/Müller/Habegger (Editor[s]), "Swiss Rules of International Arbitration"
2. Auflage, Zurich/New York 2013



Die freie Arztwahl in Alters- und Pflegeheimen - Herausforderungen aufgrund des neuen Erwachsenenschutzrechts(The free choice of doctor in retirement and nursing homes - challenges posed by the new "Adult Protection Law")

by Kerstin Noëlle Vokinger
co-authored by Tomas Poledna
in: "Pfegerecht - Pflegewissenschaft" 1 August 2013, pp. 66-75


Krankenversicherungen und politische Meinungsbildung - Mögliches und Unmögliches(Health insurance and the formation of political opinion - the possible and the impossible)

by Kerstin Noëlle Vokinger
co-authored by Thomas Poledna
in: "Jusletter" 1 August 2013



Telemedizin und ärztliches Rezept(Telemedicine and the doctor's prescription)

by Kerstin Noëlle Vokinger
co-authored by Tomas Poledna
in: "AJP" 1 February 2013, pp. 223 ff.


Kommentar zu Art. 162 und 163 der Handelsregisterverordnung (Handelsregistersperre)(Commentary on art. 162 and 163 of the Commercial Register Ordinance (Blocking of the Commercial Register))

by Antonio Carbonara
in: "Handelsregisterverordnung (HRegV) – Stämpflis Handkommentar"
Bern 2013, pp. 1445–1501



Outsourcing 2014

co-authored by David Vasella and Nicola Benz
in: "Getting the Deal Through"
London 2013


Rezension: Max Giger/Urs Saxer/Andreas Wildi/Markus B. Fritz, Arzneimittelrecht(Review: Max Giger/Urs Saxer/Andreas Wildi/Markus B. Fritz, pharmaceutical law)

by Kerstin Noëlle Vokinger
in: "HILL" 104/2013


Abgabe und Vertrieb von Medizinprodukten(Sale and distribution of medicinal products)

by Kerstin Noëlle Vokinger
co-authored by Tomas Poledna
in: "Tagungsband Medizinprodukte: Regulierung und Haftung" 1 January 2013, pp. 149-169


Costs in International Arbitration

co-authored by Micha Bühler and Marco Stacher
in: Manuel Arroyo (Editor[s]), "Arbitration in Switzerland – The Practitioner’s Guide"
The Hague 2013



Ausgewählte Entwicklungen im schweizerischen Kartellrecht 2011/2012(Selected developments in Swiss Antitrust Law 2011/2012)

by Daniel Zimmerli
in: "Aktuelle Anwaltspraxis" 2013, p. 897



Gutachten im Auftrag des Bundesamtes für Gesundheit - HIV-Test und Informed Consent(Report written on behalf of the Federal Office of Public Health - HIV-test and informed consent)

by Kerstin Noëlle Vokinger
co-authored by Thomas Gächter
in: "Jusletter" 1 October 2012



Rezension: Melanie Frey Wick/Markus Frey, Die Arztpraxis in der Schweiz(Review: Melanie Frey Wick/Markus Frey, medical practice in Switzerland)

by Kerstin Noëlle Vokinger
in: "HILL" 19/2012


Das Berufsrecht in der Arzt-Patienten-Beziehung - veranschaulicht an einem Fallbeispiel(The role of the laws governing the liberal professions in the doctor-patient relationship - illustrated in a case study)

by Kerstin Noëlle Vokinger
in: "HILL" 28/2012


Personalisierte Medizin aus juristischer Perspektive(Personalised medicine from a legal perspective)

by Kerstin Noëlle Vokinger
co-authored by Thomas Gächter
in: "PRAXIS" 15/2012, pp. 965-969


Rezension Brigitte Tag/Dominik Gross (Hrsg.), Tod im Gefängnis - Hungerstreik, Suizid, Todesstrafe und "normaler" Tod aus rechtlicher, historischer und ethischer Sicht(Review Brigitte Tag/Dominik Gross (ed.), Death in prison - hunger strike, suicide, the death penalty and "normal" death from a legal, historical and ethical perspective)

by Kerstin Noëlle Vokinger
in: "HILL" 39/2012


Country Answer for Switzerland

co-authored by Philipp Habegger and Micha Bühler
in: "ICC Guide to National Procedures for Recognition and Enforcement of Awards under the New York Convention Awards, ICC International Court of Arbitration Bulletin" Vol 23/Special Supplement – 2012



ZH · Schweizer Kennzeichenrecht für Praktiker(Swiss law on signs (Trademark company names etc.))

Speaker: Demian Stauber
Europäische Anwaltsvereinigung
Potsdam 15 November 2011


Use of Share Purchase Agreements in European Jurisdictions: Switzerland

co-authored by Micha Fankhauser and Alex Nikitine
in: Jaletzke/Henle/Beck (Editor[s]), "M&A Agreements in Germany"
Munich 2011, pp. 348–359




Der Rechtsschutz im Immaterialgüter- und Wettbewerbsrecht(Remedies in Swiss Intellectual Property and Competition Law)

co-authored by Lucas David, Markus R. Frick, Oliver M. Kunz, Matthias U. Studer and Daniel Zimmerli
in: von Büren/David (Editor[s]), "Schweizerisches Immaterialgüter- und Wettbewerbsrecht (SIWR)"
3. Auflage, Basel/Geneva/Munich 2011









Inverkehrbringen und Bewerbung von Arznei- und Nahrungsmitteln(Introduction and application of medicines and foodstuffs Placing and marketing of drugs and foods)

by Maurice Courvoisier
co-authored by Reto Vonzun
in: "WirtschaftsBild" 1 April 2009, p. 2


Die aktienrechtliche Organverantwortlichkeit nach Art. 754 Abs. 1 OR als Folge unternehmerischer Fehlentscheide: Konzeption und Ausgestaltung der «Business Judgment Rule» im Gefüge der Corporate Governance(The liability of the Board of Directors and Managers under Article 754 para. 1 CO for business judgements: Concept and structure of the business judgement rule in the Corporate Governance context)

by Alex Nikitine
Zurich 2007 (Dissertation)


Golden Handshakes, Golden Parachutes und ähnliche Vereinbarungen bei M&A-Transaktionen(Golden Handshakes, Golden Parachutes and similar arrangements in M&A transactions)

co-authored by Alex Nikitine
in: Rudolf Tschäni (Editor[s]), "Mergers & Acquisitions IX"
Zurich 2007 (Sonderdruck aus Europa Institut Zürich, Band 79)



USZ – wie weiter?(Corporate Governance at the Zurich University Clinic)

co-authored by Hans Rudolf Trüeb
in: "Neue Zürcher Zeitung (NZZ)" 1 July 2006






Werbung für Lebensmittel(Advertising for food)

by Markus R. Frick
in: "Lebensmittelrecht"
Berne 2006


Das behinderte Kind im Sozialversicherungsrecht(The Disabled Child and the Swiss Social Insurance Law)

by Saskia Cruchon
in: "Das behinderte Kind im schweizerischen Recht"
Zurich/Basel/Geneva 2006


Der Ermessensspielraum der Behörden im Rahmen des Tariffestsetzungsverfahrens nach Art. 47 in Verbindung mit Art. 53 Krankenversicherungsgesetz(The discretion of the authorities in the tariffication according to art. 47 in conjunction with art. 53 of the Swiss Code of Medical Insurance)

co-authored by Daniel Staffelbach and Yves Endass
in: Tomas Poledna (Editor[s]), "Forum Gesundheitsrecht"
Zurich/Basel/Geneva 2005


Argument Gesundheit in der Werbung(Health arguments in advertising)

by Markus R. Frick
in: "Forum Gesundheitsrecht"
Zurich 2005





Sanktionierung von Informationsrechtsverletzungen(Sanctions for violations of information confidentiality rules)

co-authored by Tomas Poledna and Stefano Codoni
in: Bruno Baeriswyl/Beat Rudin (Editor[s]), "Perspektive Datenschutz"
Zurich 2002, pp. 265–290


Abwerbung von Personal und Kunden, unter besonderer Berücksichtigung der Abwerbung durch Arbeitnehmer(Solicitation of Employees and Customers, in particular Solicitation Carried Out by Employees)

by Markus R. Frick
Zurich 2000 (Dissertation)


Anmerkung zum Entscheid des Eidg. Versicherungsgerichtes vom 20. Dezember 1999; Regelungsfreiheit der Krankenversicherer, Gesundheitskassen und HMO-Versicherungen in der Einschränkung der freien Wahl der Leistungserbringer im KVG(Case note on Federal Insurance Court decision of 20 December 1999 re medical insurance)

by Daniel Staffelbach
in: "Aktuelle Juristische Praxis (AJP)" 7/2000, pp. 889–891


Markt oder Planwirtschaft? Das neue Kartellgesetz ist auch im Gesundheitswesen zu beachten

by Reto Jacobs
in: "Handelszeitung" 21 October 1998, p. 25